Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Wish You Were Here: Oklahoma Frontier Drug Store Museum

Author(s):  Worthen Dennis B

Issue:  May/Jun 2000 - Compounding for the Ear, Nose and Throat
View All Articles in Issue

Page(s):  188-189

Wish You Were Here: Oklahoma Frontier Drug Store Museum Page 1
Wish You Were Here: Oklahoma Frontier Drug Store Museum Page 2

Download in electronic PDF format for $75

Abstract:  Today Guthrie, OK, contains one of the largest urban historic districts on the National Register. It consists of 400 city blocks and over 2,000 historic structures, including the Oklahoma Frontier Drug Store Museum, which occupies the first floor of the Gaffney Building, built in 1890 as the first permanent home of the Lillie Drug Store. The museum is a result of the efforts of the Oklahoma Pharmacy Heritage Foundation and was established in 1992. Many of the furnishings are from the territorial period. In addition to describing the contents of exhibits, the author provides information as to location, phone number, hours open and admission fee.

Related Keywords: cleo drug store, Drug Store, frontier, Indian

Related Categories: HISTORY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Wish You Were Here: Oklahoma Frontier Drug Store Museum
Worthen Dennis B
May/Jun 2000
Pg. 188-189

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Wish You Were Here: Deutsche Apotheken Museum (German Museum of Pharmacy)
Worthen Dennis B
Jan/Feb 2003
Pg. 78-79

Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
May/Jun 2016
Pg. 202-206

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
Nov/Dec 2012
Pg. 456-460

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
Jul/Aug 2022
Pg. 298-301

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351

Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Kramer Mark A
, Grilley Bambi J
Jul/Aug 2002
Pg. 271-273

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna
, Jones William, Stephenson Douglas M M
May/Jun 2006
Pg. 175-183

PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 268

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase
, Bernard Brian, Cogdill Christopher Blake
Sep/Oct 2015
Pg. 377-380

Return to Top